Improved insulin sensitivity by anti-TNFalpha antibody treatment in patients with rheumatic diseases.
作者信息
Huvers Frank C, Popa Calin, Netea Mihai G, van den Hoogen Frank H J, Tack Cees J
出版信息
Ann Rheum Dis. 2007 Apr;66(4):558-9. doi: 10.1136/ard.2006.062323.
Abstract
摘要
相似文献
1
Improved insulin sensitivity by anti-TNFalpha antibody treatment in patients with rheumatic diseases.抗TNFα抗体治疗改善风湿性疾病患者的胰岛素敏感性。
Ann Rheum Dis. 2007 Apr;66(4):558-9. doi: 10.1136/ard.2006.062323.
2
[Are there differences among anti-TNFα biological drugs?].抗TNFα生物药物之间存在差异吗？
Reumatismo. 2005;57(4 Suppl):1-2. doi: 10.4081/reumatismo.2005.4s.1.
3
The application of infliximab (Remicade), a chimeric monoclonal antibody, in the treatment of rheumatic diseases.嵌合单克隆抗体英夫利昔单抗（类克）在风湿性疾病治疗中的应用。
Isr Med Assoc J. 2000 Dec;2 Suppl:11-2.
4
Insulin resistance in patients with rheumatoid arthritis: effect of anti-TNFalpha therapy.类风湿关节炎患者的胰岛素抵抗：抗TNFα治疗的影响
Scand J Rheumatol. 2007 Mar-Apr;36(2):91-6. doi: 10.1080/03009740601179605.
5
Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis.英夫利昔单抗治疗对类风湿关节炎和强直性脊柱炎患者胰岛素抵抗的影响。
Ann Rheum Dis. 2005 May;64(5):765-6. doi: 10.1136/ard.2004.026534. Epub 2004 Sep 30.
6
Infliximab treatment for rheumatic disease: clinical and radiological efficacy.英夫利昔单抗治疗风湿性疾病：临床及影像学疗效
Ann Rheum Dis. 2002 Nov;61 Suppl 2(Suppl 2):ii67-9. doi: 10.1136/ard.61.suppl_2.ii67.
7
The use of tumor necrosis factor neutralization strategies in rheumatologic disorders other than rheumatoid arthritis in Lebanon.肿瘤坏死因子中和策略在黎巴嫩类风湿关节炎以外的风湿性疾病中的应用。
Semin Arthritis Rheum. 2004 Jun;33(6):422-3. doi: 10.1016/j.semarthrit.2003.12.005.
8
Anti-tumour necrosis factor agents and lipid profile: a class effect?抗肿瘤坏死因子药物与血脂谱：类效应？
Ann Rheum Dis. 2008 Jun;67(6):895-6. doi: 10.1136/ard.2007.078287.
9
[Approved indications and other possible utilizations of anti-TNFα biologic drugs].[抗TNFα生物药物的批准适应症及其他可能用途]
Reumatismo. 2005;57(4 Suppl):30-3. doi: 10.4081/reumatismo.2005.4s.30.
10
[Influence of tumor necrosis alpha blockade with infliximab on lipid profile in patients with active rheumatoid arthritis].
Med Clin (Barc). 2006 May 20;126(19):757. doi: 10.1157/13088951.
引用本文的文献
1
Novel perspectives on autophagy-oxidative stress-inflammation axis in the orchestration of adipogenesis.自噬-氧化应激-炎症轴在脂肪生成中的调控作用的新观点。
Front Endocrinol (Lausanne). 2024 Jun 24;15:1404697. doi: 10.3389/fendo.2024.1404697. eCollection 2024.
2
Relevance and consequence of chronic inflammation for obesity development.慢性炎症对肥胖发展的相关性及影响
Mol Cell Pediatr. 2023 Nov 14;10(1):16. doi: 10.1186/s40348-023-00170-6.
3
Physical Activity as a Modern Intervention in the Fight against Obesity-Related Inflammation in Type 2 Diabetes Mellitus and Gestational Diabetes.体育活动作为对抗2型糖尿病和妊娠期糖尿病中肥胖相关炎症的现代干预措施
Antioxidants (Basel). 2023 Jul 25;12(8):1488. doi: 10.3390/antiox12081488.
4
Inflammation in obesity, diabetes, and related disorders.肥胖、糖尿病及相关紊乱中的炎症。
Immunity. 2022 Jan 11;55(1):31-55. doi: 10.1016/j.immuni.2021.12.013.
5
Anti- and non-tumor necrosis factor-α-targeted therapies effects on insulin resistance in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.抗肿瘤坏死因子-α和非肿瘤坏死因子-α靶向治疗对类风湿关节炎、银屑病关节炎和强直性脊柱炎胰岛素抵抗的影响。
World J Diabetes. 2021 Mar 15;12(3):238-260. doi: 10.4239/wjd.v12.i3.238.
6
Piperine ameliorates insulin resistance via inhibiting metabolic inflammation in monosodium glutamate-treated obese mice.胡椒碱通过抑制谷氨酸钠处理肥胖小鼠的代谢性炎症改善胰岛素抵抗。
BMC Endocr Disord. 2020 Oct 7;20(1):152. doi: 10.1186/s12902-020-00617-1.
7
Recombinant Soluble TNF-α Receptor Fusion Protein Therapy Reduces Insulin Resistance in Non-Diabetic Active Rheumatoid Arthritis Patients.重组可溶性肿瘤坏死因子-α受体融合蛋白疗法可降低非糖尿病活动期类风湿关节炎患者的胰岛素抵抗。
ACR Open Rheumatol. 2020 Jul;2(7):401-406. doi: 10.1002/acr2.11157. Epub 2020 Jun 12.
8
3D TECA hydrogel reduces cellular senescence and enhances fibroblasts migration in wound healing.3D TECA水凝胶可减少细胞衰老并增强成纤维细胞在伤口愈合中的迁移。
Asian J Pharm Sci. 2018 Jul;13(4):317-325. doi: 10.1016/j.ajps.2017.12.003. Epub 2017 Dec 8.
9
The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives.炎症在糖尿病中的作用：当前概念与未来展望
Eur Cardiol. 2019 Apr;14(1):50-59. doi: 10.15420/ecr.2018.33.1.
10
Inflammation in the Pathophysiology and Therapy of Cardiometabolic Disease.在心脏代谢疾病的病理生理学和治疗中的炎症反应
Endocr Rev. 2019 Aug 1;40(4):1080-1091. doi: 10.1210/er.2019-00002.
本文引用的文献
1
Adipose tissue, adipokines, and inflammation.脂肪组织、脂肪因子与炎症
J Allergy Clin Immunol. 2005 May;115(5):911-9; quiz 920. doi: 10.1016/j.jaci.2005.02.023.
2
Inflammation, stress, and diabetes.炎症、压力与糖尿病。
J Clin Invest. 2005 May;115(5):1111-9. doi: 10.1172/JCI25102.
3
Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis.英夫利昔单抗治疗对类风湿关节炎和强直性脊柱炎患者胰岛素抵抗的影响。
Ann Rheum Dis. 2005 May;64(5):765-6. doi: 10.1136/ard.2004.026534. Epub 2004 Sep 30.
4
Improvement of insulin sensitivity in insulin resistant subjects during prolonged treatment with the anti-TNF-alpha antibody infliximab.
Eur J Clin Invest. 2004 Sep;34(9):641-2. doi: 10.1111/j.1365-2362.2004.01390.x.
5
Caffeine can decrease insulin sensitivity in humans.咖啡因会降低人体的胰岛素敏感性。
Diabetes Care. 2002 Feb;25(2):364-9. doi: 10.2337/diacare.25.2.364.
6
Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone.肥胖/胰岛素抵抗状态下胰岛素诱导的血管舒张及内皮功能。曲格列酮的作用。
Diabetologia. 1998 May;41(5):569-76. doi: 10.1007/s001250050948.
7
Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function.缺乏肿瘤坏死因子-α功能的小鼠对肥胖诱导的胰岛素抵抗具有保护作用。
Nature. 1997 Oct 9;389(6651):610-4. doi: 10.1038/39335.
8
Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM.一种工程化人抗TNF-α抗体（CDP571）对非胰岛素依赖型糖尿病患者胰岛素敏感性和血糖控制的影响。
Diabetes. 1996 Jul;45(7):881-5. doi: 10.2337/diab.45.7.881.
9
Impaired glucose handling in active rheumatoid arthritis: relationship to the secretion of insulin and counter-regulatory hormones.活动期类风湿关节炎患者的葡萄糖处理受损：与胰岛素及反调节激素分泌的关系。
Metabolism. 1987 Oct;36(10):940-3. doi: 10.1016/0026-0495(87)90128-4.
Zotero 插件